Report: Pharma Sees Reputation Bump Among Patient Groups

A recent survey suggests the pharmaceutical industry has seen a slight bump in reputation among patient organizations, STAT reports.

The survey by PatientView found that 46 percent of patient advocacy groups believed brand-name companies had developed a better reputation last year, according to the report, a slight increase from 41 percent the previous year.

To read the full report on STAT, click here. (Paid subscription required)